2021-03-18T09:33:27Z
2021-03-18T09:33:27Z
2019
2021-03-18T09:33:27Z
Objective: To determine the percentage of patients given standard doses of piperacillin/tazobactam or meropenem by continuous infusion who achieved the target pharmacokinetic/pharmacodynamic (PK/PD) index, which was defined as free concentrations four times more than the minimum inhibitory KEYWORDS Beta-lactams; Critical care; Pharmacokinetics; Drug monitoring; Piperacillin; Meropenem.
Article
Published version
English
Antibiòtics betalactàmics; Medicina intensiva; Farmacocinètica; Beta lactam antibiotics; Critical care medicine; Pharmacokinetics
Sociedad Española de Farmacia Hospitalaria
Reproducció del document publicat a: https://doi.org/10.7399/fh.11170
Farmacia Hospitalaria, 2019
https://doi.org/10.7399/fh.11170
cc by-nc-sa (c) Sociedad Española de Farmacia Hospitalaria, 2019
http://creativecommons.org/licenses/by-nc-sa/3.0/es/